A carregar...
Latrepirdine for Alzheimer's disease
BACKGROUND: Current treatments for Alzheimer’s disease (AD) provide modest symptomatic relief but do not slow the progression of the disease. Latrepirdine may modulate several targets involved in AD pathology, including lipid peroxidation, mitochondrial permeability, voltage‐gated calcium ion channe...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2015
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7388906/ https://ncbi.nlm.nih.gov/pubmed/25897825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009524.pub2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|